factual

MDMA Phase 3 Removed PTSD Diagnosis in 70%

Across two Phase 3 studies of MDMA-assisted therapy for PTSD—the first with severe PTSD and the replication with moderate-to-severe PTSD—roughly 70% of participants lost their PTSD diagnosis, with remarkably similar outcomes across both studies despite the broadened population, a result far exceeding current gold-standard treatments.

factualpending

Speaker

Jennifer Mitchell

Evidence Quote

“approximately what 70 of the participants over the course of the two study lost their diagnosis of ptsd”

Source

377 - The Future Of Psychedelic Medicine 2— Making Sense with Sam Harris
Created: 6/14/2026, 2:01:41 AM

Your notes

Loading notes...